Bi, Jianling
Zhang, Yuping
Malmrose, Paige K.
Losh, Haley A.
Newtson, Andreea M.
Devor, Eric J.
Thiel, Kristina W.
Leslie, Kimberly K. https://orcid.org/0000-0002-2704-8990
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (R01CA099908)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (R01CA184101)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (P30CA086862)
U.S. Department of Health & Human Services | NIH | National Cancer Institute
United States Department of Defense | United States Army | Army Medical Command | Congressionally Directed Medical Research Programs (OC190352)
U.S. Department of Health & Human Services | NIH | National Center for Advancing Translational Sciences (UL1TR002537)
U.S. Department of Health & Human Services | NIH | National Cancer Institute
Article History
Received: 30 September 2021
Revised: 6 December 2021
Accepted: 20 December 2021
First Online: 17 January 2022
Ethics approval and consent to participate
: This study was approved by the University of Iowa Institutional Review Board (IRB, # 201809807). Informed consent was obtained from all subjects involved in the study. All animal studies were performed under animal protocol #0022285-003 approved by the University of Iowa Institutional Animal Care and Use Committee.
: KWT is a co-founder of Immortagen, Inc. All other authors declare that they have no competing interests.